1jpy › Citations

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.

Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA
EMBO J 20 5332-41 (2001)
Cited: 313 times
EuropePMC logo PMID: 11574464

Abstract

The proinflammatory cytokine interleukin 17 (IL-17) is the founding member of a family of secreted proteins that elicit potent cellular responses. We report a novel human IL-17 homolog, IL-17F, and show that it is expressed by activated T cells, can stimulate production of other cytokines such as IL-6, IL-8 and granulocyte colony-stimulating factor, and can regulate cartilage matrix turnover. Unexpectedly, the crystal structure of IL-17F reveals that IL-17 family members adopt a monomer fold typical of cystine knot growth factors, despite lacking the disulfide responsible for defining the canonical "knot" structure. IL-17F dimerizes in a parallel manner like neurotrophins, and features an unusually large cavity on its surface. Remarkably, this cavity is located in precisely the same position where nerve growth factor binds its high affinity receptor, TrkA, suggesting further parallels between IL-17s and neurotrophins with respect to receptor recognition.

Articles - 1jpy mentioned but not cited (10)

  1. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA. EMBO J. 20 5332-5341 (2001)
  2. Structural basis of receptor sharing by interleukin 17 cytokines. Ely LK, Fischer S, Garcia KC. Nat. Immunol. 10 1245-1251 (2009)
  3. Structural architecture and functional evolution of Wnts. Bazan JF, Janda CY, Garcia KC. Dev. Cell 23 227-232 (2012)
  4. Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide. Liu S, Desharnais J, Sahasrabudhe PV, Jin P, Li W, Oates BD, Shanker S, Banker ME, Chrunyk BA, Song X, Feng X, Griffor M, Jimenez J, Chen G, Tumelty D, Bhat A, Bradshaw CW, Woodnutt G, Lappe RW, Thorarensen A, Qiu X, Withka JM, Wood LD. Sci Rep 6 26071 (2016)
  5. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  6. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties. Goepfert A, Lehmann S, Wirth E, Rondeau JM. Sci Rep 7 8906 (2017)
  7. Modulation of IL-17 backbone dynamics reduces receptor affinity and reveals a new inhibitory mechanism. Shaw DJ, Waters LC, Strong SL, Schulze MED, Greetham GM, Towrie M, Parker AW, Prosser CE, Henry AJ, Lawson ADG, Carr MD, Taylor RJ, Hunt NT, Muskett FW. Chem Sci 14 7524-7536 (2023)
  8. Protein-Catalyzed Capture Agents. Agnew HD, Coppock MB, Idso MN, Lai BT, Liang J, McCarthy-Torrens AM, Warren CM, Heath JR. Chem. Rev. 119 9950-9970 (2019)
  9. Case Reports Role of nitric oxide-scavenging activity of Karanjin and Pongapin in the treatment of Psoriasis. Ghosh A, Tiwari GJ. 3 Biotech 8 338 (2018)
  10. Structural Basis for How Biologic Medicines Bind their Targets in Psoriasis Therapy. Eldirany SA, Ho M, Bunick CG. Yale J Biol Med 93 19-27 (2020)


Reviews citing this publication (126)

  1. IL-17 and Th17 Cells. Korn T, Bettelli E, Oukka M, Kuchroo VK. Annu. Rev. Immunol. 27 485-517 (2009)
  2. Interleukin-17 family members and inflammation. Kolls JK, Lindén A. Immunity 21 467-476 (2004)
  3. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Weaver CT, Hatton RD, Mangan PR, Harrington LE. Annu. Rev. Immunol. 25 821-852 (2007)
  4. The biological functions of T helper 17 cell effector cytokines in inflammation. Ouyang W, Kolls JK, Zheng Y. Immunity 28 454-467 (2008)
  5. Induction and effector functions of T(H)17 cells. Bettelli E, Korn T, Oukka M, Kuchroo VK. Nature 453 1051-1057 (2008)
  6. CD4 T cells: fates, functions, and faults. Zhu J, Paul WE. Blood 112 1557-1569 (2008)
  7. Structure and signalling in the IL-17 receptor family. Gaffen SL. Nat. Rev. Immunol. 9 556-567 (2009)
  8. TH17 cells in development: an updated view of their molecular identity and genetic programming. Dong C. Nat. Rev. Immunol. 8 337-348 (2008)
  9. Functional specialization of interleukin-17 family members. Iwakura Y, Ishigame H, Saijo S, Nakae S. Immunity 34 149-162 (2011)
  10. Interleukin-17 family and IL-17 receptors. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Cytokine Growth Factor Rev. 14 155-174 (2003)
  11. Targeting IL-17 and TH17 cells in chronic inflammation. Miossec P, Kolls JK. Nat Rev Drug Discov 11 763-776 (2012)
  12. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Saenz SA, Taylor BC, Artis D. Immunol. Rev. 226 172-190 (2008)
  13. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Lubberts E, Koenders MI, van den Berg WB. Arthritis Res. Ther. 7 29-37 (2005)
  14. Protumor vs antitumor functions of IL-17. Murugaiyan G, Saha B. J Immunol 183 4169-4175 (2009)
  15. TH17 cells in asthma and COPD. Alcorn JF, Crowe CR, Kolls JK. Annu. Rev. Physiol. 72 495-516 (2010)
  16. An overview of IL-17 function and signaling. Gaffen SL. Cytokine 43 402-407 (2008)
  17. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Gaffen SL, Hajishengallis G. J. Dent. Res. 87 817-828 (2008)
  18. IL-17 cytokine family. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. J. Allergy Clin. Immunol. 114 1265-73; quiz 1274 (2004)
  19. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Lubberts E. Cytokine 41 84-91 (2008)
  20. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Shen F, Gaffen SL. Cytokine 41 92-104 (2008)
  21. IL-17 family: cytokines, receptors and signaling. Gu C, Wu L, Li X. Cytokine 64 477-485 (2013)
  22. Immunity in Drosophila melanogaster--from microbial recognition to whole-organism physiology. Buchon N, Silverman N, Cherry S. Nat. Rev. Immunol. 14 796-810 (2014)
  23. Reparative inflammation takes charge of tissue regeneration. Karin M, Clevers H. Nature 529 307-315 (2016)
  24. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Immunol Rev 226 87-102 (2008)
  25. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Zhu S, Qian Y. Clin. Sci. 122 487-511 (2012)
  26. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Pappu R, Ramirez-Carrozzi V, Sambandam A. Immunology 134 8-16 (2011)
  27. IL-17 family member cytokines: regulation and function in innate immunity. Reynolds JM, Angkasekwinai P, Dong C. Cytokine Growth Factor Rev. 21 413-423 (2010)
  28. Interleukin-17 and its expanding biological functions. Xu S, Cao X. Cell. Mol. Immunol. 7 164-174 (2010)
  29. Signaling of interleukin-17 family cytokines in immunity and inflammation. Chang SH, Dong C. Cell. Signal. 23 1069-1075 (2011)
  30. Th17 cytokines and arthritis. Lubberts E. Semin Immunopathol 32 43-53 (2010)
  31. IL-17 and the Th17 lineage in systemic lupus erythematosus. Garrett-Sinha LA, John S, Gaffen SL. Curr Opin Rheumatol 20 519-525 (2008)
  32. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Ley K, Smith E, Stark MA. Immunol. Res. 34 229-242 (2006)
  33. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. Kramer JM, Gaffen SL. J. Periodontol. 78 1083-1093 (2007)
  34. The IL-17 Family of Cytokines in Health and Disease. McGeachy MJ, Cua DJ, Gaffen SL. Immunity 50 892-906 (2019)
  35. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Hundorfean G, Neurath MF, Mudter J. Inflamm. Bowel Dis. 18 180-186 (2012)
  36. Role of IL-17 in psoriasis and psoriatic arthritis. Raychaudhuri SP. Clin Rev Allergy Immunol 44 183-193 (2013)
  37. IL-17F: regulation, signaling and function in inflammation. Chang SH, Dong C. Cytokine 46 7-11 (2009)
  38. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. Akdis M, Palomares O, van de Veen W, van Splunter M, Akdis CA. J. Allergy Clin. Immunol. 129 1438-49; quiz1450-1 (2012)
  39. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, Frei R, Garbani M, Globinska A, Hess L, Huitema C, Kubo T, Komlosi Z, Konieczna P, Kovacs N, Kucuksezer UC, Meyer N, Morita H, Olzhausen J, O'Mahony L, Pezer M, Prati M, Rebane A, Rhyner C, Rinaldi A, Sokolowska M, Stanic B, Sugita K, Treis A, van de Veen W, Wanke K, Wawrzyniak M, Wawrzyniak P, Wirz OF, Zakzuk JS, Akdis CA. J. Allergy Clin. Immunol. 138 984-1010 (2016)
  40. IL-17 targeted therapies for psoriasis. Chiricozzi A, Krueger JG. Expert Opin Investig Drugs 22 993-1005 (2013)
  41. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Hizawa N, Kawaguchi M, Huang SK, Nishimura M. Clin. Exp. Allergy 36 1109-1114 (2006)
  42. The potential role of interleukin-17 in severe asthma. Wang YH, Wills-Karp M. Curr Allergy Asthma Rep 11 388-394 (2011)
  43. Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis. Gaffen SL. Arthritis Res. Ther. 6 240-247 (2004)
  44. The IL-17 cytokine family and their role in allergic inflammation. Wang YH, Liu YJ. Curr. Opin. Immunol. 20 697-702 (2008)
  45. Interleukin 17 is a chief orchestrator of immunity. Veldhoen M. Nat. Immunol. 18 612-621 (2017)
  46. Recent advances in asthma genetics. Zhang J, Paré PD, Sandford AJ. Respir. Res. 9 4 (2008)
  47. The IL-17 family cytokines in immunity and disease. Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y. J. Clin. Immunol. 30 185-195 (2010)
  48. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Kabir S. Helicobacter 16 1-8 (2011)
  49. Interleukin-17 as a drug target in human disease. Ivanov S, Lindén A. Trends Pharmacol. Sci. 30 95-103 (2009)
  50. Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases. Chen J, Liu X, Zhong Y. Front Aging Neurosci 12 566922 (2020)
  51. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Hu Y, Shen F, Crellin NK, Ouyang W. Ann. N. Y. Acad. Sci. 1217 60-76 (2011)
  52. IL-17RC: a partner in IL-17 signaling and beyond. Ho AW, Gaffen SL. Semin Immunopathol 32 33-42 (2010)
  53. Structural biology of glycoprotein hormones and their receptors: insights to signaling. Jiang X, Dias JA, He X. Mol. Cell. Endocrinol. 382 424-451 (2014)
  54. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Song X, Qian Y. Cell. Signal. 25 2335-2347 (2013)
  55. Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Mai J, Wang H, Yang XF. Front Biosci (Landmark Ed) 15 986-1006 (2010)
  56. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. Ngalamika O, Zhang Y, Yin H, Zhao M, Gershwin ME, Lu Q. J. Autoimmun. 39 451-465 (2012)
  57. Protein domain analysis in the era of complete genomes. Copley RR, Doerks T, Letunic I, Bork P. FEBS Lett. 513 129-134 (2002)
  58. Survey of the year 2001 commercial optical biosensor literature. Rich RL, Myszka DG. J. Mol. Recognit. 15 352-376 (2002)
  59. T helper 17 cells in airway diseases: from laboratory bench to bedside. Halwani R, Al-Muhsen S, Hamid Q. Chest 143 494-501 (2013)
  60. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis. Azizi G, Jadidi-Niaragh F, Mirshafiey A. Int J Rheum Dis 16 243-253 (2013)
  61. IL-17 signaling in host defense and inflammatory diseases. Qian Y, Kang Z, Liu C, Li X. Cell. Mol. Immunol. 7 328-333 (2010)
  62. The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity. Song X, He X, Li X, Qian Y. Cell. Mol. Immunol. 13 418-431 (2016)
  63. A tale of two cytokines: IL-17 and IL-22 in asthma and infection. Manni ML, Robinson KM, Alcorn JF. Expert Rev Respir Med 8 25-42 (2014)
  64. Structure and function of interleukin-17 family cytokines. Zhang X, Angkasekwinai P, Dong C, Tang H. Protein Cell 2 26-40 (2011)
  65. IL-25: a key requirement for the regulation of type-2 immunity. Barlow JL, McKenzie AN. Biofactors 35 178-182 (2009)
  66. The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection. Bagheri N, Azadegan-Dehkordi F, Shirzad H, Rafieian-Kopaei M, Rafieian-Kopaei M, Rahimian G, Razavi A. Microb. Pathog. 81 33-38 (2015)
  67. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Raychaudhuri SK, Saxena A, Raychaudhuri SP. Clin. Rheumatol. 34 1019-1023 (2015)
  68. Potential involvement of IL-17F in asthma. Ota K, Kawaguchi M, Matsukura S, Kurokawa M, Kokubu F, Fujita J, Morishima Y, Huang SK, Ishii Y, Satoh H, Hizawa N. J Immunol Res 2014 602846 (2014)
  69. Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines. Pappu BP, Angkasekwinai P, Dong C. Pharmacol. Ther. 117 374-384 (2008)
  70. Th17 cell cytokine secretion profile in host defense and autoimmunity. Graeber KE, Olsen NJ. Inflamm. Res. 61 87-96 (2012)
  71. Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis. Volpe E, Battistini L, Borsellino G. Mediators Inflamm. 2015 475158 (2015)
  72. Barrier immunity and IL-17. Marks BR, Craft J. Semin. Immunol. 21 164-171 (2009)
  73. Recent progress in host immunity to avian coccidiosis: IL-17 family cytokines as sentinels of the intestinal mucosa. Min W, Kim WH, Lillehoj EP, Lillehoj HS. Dev. Comp. Immunol. 41 418-428 (2013)
  74. IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders. Strzępa A, Szczepanik M. Pharmacol Rep 63 30-44 (2011)
  75. Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes. Kumar P, Subramaniyam G. Cytokine 71 366-376 (2015)
  76. Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors. Kang J, Malhotra N. Annu. Rev. Immunol. 33 505-538 (2015)
  77. Protective role of Th17 cells in pulmonary infection. Rathore JS, Wang Y. Vaccine 34 1504-1514 (2016)
  78. The Function of Fish Cytokines. Zou J, Secombes CJ. Biology (Basel) 5 (2016)
  79. IL-23/IL-17 axis in spondyloarthritis-bench to bedside. Raychaudhuri SP, Raychaudhuri SK. Clin. Rheumatol. 35 1437-1441 (2016)
  80. Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B. World J Orthop 5 516-536 (2014)
  81. Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications. Monin L, Gaffen SL. Cold Spring Harb Perspect Biol 10 (2018)
  82. Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis. Brockmann L, Giannou AD, Gagliani N, Huber S. Int J Mol Sci 18 (2017)
  83. Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis. Durham LE, Kirkham BW, Taams LS. Curr Rheumatol Rep 17 55 (2015)
  84. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Anderson EJ, McGrath MA, Thalhamer T, McInnes IB. Springer Semin. Immunopathol. 27 425-442 (2006)
  85. Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases. Zhang H, Bernuzzi F, Lleo A, Ma X, Invernizzi P. Mediators Inflamm. 2015 436450 (2015)
  86. Cytokine crowdsourcing: multicellular production of TH17-associated cytokines. Busman-Sahay KO, Walrath T, Huber S, O'Connor W. J. Leukoc. Biol. 97 499-510 (2015)
  87. IL-25 in allergic inflammation. Xu M, Dong C. Immunol. Rev. 278 185-191 (2017)
  88. Asthma biomarkers in the age of biologics. Kim H, Ellis AK, Fischer D, Noseworthy M, Olivenstein R, Chapman KR, Lee J. Allergy Asthma Clin Immunol 13 48 (2017)
  89. Cytokines in Drosophila immunity. Vanha-Aho LM, Valanne S, Rämet M. Immunol. Lett. 170 42-51 (2016)
  90. The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis. Wacleche VS, Landay A, Routy JP, Ancuta P. Viruses 9 (2017)
  91. IL-17 and IL-17-producing cells in protection versus pathology. Mills KHG. Nat Rev Immunol 23 38-54 (2023)
  92. Maternal IL-17A in autism. Wong H, Hoeffer C. Exp. Neurol. 299 228-240 (2018)
  93. Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. Li J, Casanova JL, Puel A. Mucosal Immunol 11 581-589 (2018)
  94. Drosophila Innate Immunity Involves Multiple Signaling Pathways and Coordinated Communication Between Different Tissues. Yu S, Luo F, Xu Y, Zhang Y, Jin LH. Front Immunol 13 905370 (2022)
  95. Recognition of Candida albicans and Role of Innate Type 17 Immunity in Oral Candidiasis. Pavlova A, Sharafutdinov I. Microorganisms 8 E1340 (2020)
  96. The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology. Paroli M, Caccavale R, Fiorillo MT, Spadea L, Gumina S, Candela V, Paroli MP. Pathogens 11 1547 (2022)
  97. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Blauvelt A, Chiricozzi A. Clin Rev Allergy Immunol 55 379-390 (2018)
  98. The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment. Paroli M, Spadea L, Caccavale R, Spadea L, Paroli MP, Nante N. Medicina (Kaunas) 58 1552 (2022)
  99. The Th17 Pathway in Vascular Inflammation: Culprit or Consort? Robert M, Miossec P, Hot A. Front Immunol 13 888763 (2022)
  100. IL-17 in the immunopathogenesis of spondyloarthritis. Taams LS, Steel KJA, Srenathan U, Burns LA, Kirkham BW. Nat Rev Rheumatol 14 453-466 (2018)
  101. Paget's disease of bone: an osteoimmunological disorder? Numan MS, Amiable N, Brown JP, Michou L. Drug Des Devel Ther 9 4695-4707 (2015)
  102. The role of interleukin-17 in tumor development and progression. Zhao J, Chen X, Herjan T, Li X. J Exp Med 217 (2020)
  103. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Vidal S, Puig L, Carrascosa-Carrillo JM, González-Cantero Á, Ruiz-Carrascosa JC, Velasco-Pastor AM. Int J Mol Sci 22 6740 (2021)
  104. Gene polymorphisms in asthma: a narrative review. Shi F, Zhang Y, Qiu C. Ann Transl Med 10 711 (2022)
  105. Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis. Deng C, Peng N, Tang Y, Yu N, Wang C, Cai X, Zhang L, Hu D, Ciccia F, Lu L. Front Immunol 12 691559 (2021)
  106. The Role of T Helper 17 Cells and Other IL-17-Producing Cells in Bone Resorption and Remodeling. Liu WX, Li ZJ, Niu XL, Yao Z, Deng WM. Int. Rev. Immunol. 34 332-347 (2015)
  107. Bimekizumab for the treatment of psoriatic disease. Natsis NE, Gottlieb AB. Expert Opin Biol Ther 18 1193-1197 (2018)
  108. Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer. Meehan EV, Wang K. Genes (Basel) 13 1643 (2022)
  109. Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies. Chyuan IT, Chen JY. Mediators Inflamm. 2018 2403935 (2018)
  110. The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases. Turchin I, Bourcier M. Adv Ther 39 4474-4508 (2022)
  111. The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models. Mandour M, Chen S, van de Sande MGH. Front Immunol 12 618581 (2021)
  112. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Navarro-Compán V, Puig L, Vidal S, Ramírez J, Llamas-Velasco M, Fernández-Carballido C, Almodóvar R, Pinto JA, Galíndez-Aguirregoikoa E, Zarco P, Joven B, Gratacós J, Juanola X, Blanco R, Arias-Santiago S, Sanz Sanz J, Queiro R, Cañete JD. Front Immunol 14 1191782 (2023)
  113. IL-17 and Th17 cells in systemic sclerosis: a comprehensive review. Bălănescu P, Bălănescu E, Bălănescu A. Rom J Intern Med 55 198-204 (2017)
  114. IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels. Robert M, Miossec P. Front Med (Lausanne) 5 364 (2018)
  115. Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases. Le Goff B, Bouvard B, Lequerre T, Lespessailles E, Marotte H, Pers YM, Cortet B. Mediators Inflamm. 2019 8659302 (2019)
  116. Interleukin-17 as a key player in neuroimmunometabolism. Douglas A, Stevens B, Lynch L. Nat Metab 5 1088-1100 (2023)
  117. Interleukin-17: Potential Target for Chronic Wounds. Hadian Y, Bagood MD, Dahle SE, Sood A, Isseroff RR. Mediators Inflamm. 2019 1297675 (2019)
  118. Molecular mechanisms and cell targets of Th17 cells in the gastrointestinal tract: an innate sense of adaptivity. Verdier J, Ruemmele FM. Int. Rev. Immunol. 32 475-492 (2013)
  119. Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action. Mohd Noor AA, Azlan M, Mohd Redzwan N. Biomedicines 10 498 (2022)
  120. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. Sánchez-Rodríguez G, Puig L. Int J Mol Sci 24 10305 (2023)
  121. Regulation of the mesenchymal stem cell fate by interleukin-17: Implications in osteogenic differentiation. Krstić J, Mojsilović S, Mojsilović SS, Santibanez JF. World J Stem Cells 13 1696-1713 (2021)
  122. Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases. Sisto M, Lisi S. J Clin Med 13 164 (2023)
  123. Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly. Mylle S, Grine L, Speeckaert R, Lambert JLW, van Geel N. Am J Clin Dermatol 19 625-637 (2018)
  124. The IL-17 family in diseases: from bench to bedside. Huangfu L, Li R, Huang Y, Wang S. Signal Transduct Target Ther 8 402 (2023)
  125. The Interleukin-17 Family of Cytokines in Breast Cancer. Fabre JAS, Giustinniani J, Garbar C, Merrouche Y, Antonicelli F, Bensussan A. Int J Mol Sci 19 (2018)
  126. [Psoriatic arthritis : Drugs of the (near) future]. Redelstein D, Fleck M. Z Rheumatol 76 504-508 (2017)

Articles citing this publication (177)

  1. Late developmental plasticity in the T helper 17 lineage. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, Weaver CT. Immunity 30 92-107 (2009)
  2. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y. Immunity 30 108-119 (2009)
  3. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. Science 332 65-68 (2011)
  4. Regulation of inflammatory responses by IL-17F. Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, Schluns KS, Broaddus RR, Zhu Z, Dong C. J. Exp. Med. 205 1063-1075 (2008)
  5. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J, Tocker J, Peschon J. J Immunol 177 36-39 (2006)
  6. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, Van De Veen W, Zeller S, Zimmermann M, Akdis CA. J. Allergy Clin. Immunol. 127 701-21.e1-70 (2011)
  7. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, Pirhonen J, Kolls JK. J. Immunol. 175 404-412 (2005)
  8. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B, Waisman A. J. Clin. Invest. 119 61-69 (2009)
  9. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, Collins M, Goldman SJ, Dunussi-Joannopoulos K, Williams CM, Wright JF, Fouser LA. J Immunol 179 7791-7799 (2007)
  10. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, Evans RT, Gaffen SL. Blood 109 3794-3802 (2007)
  11. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K, Harder B, Okada S, Ostrander CD, Kreindler JL, Aujla SJ, Reardon B, Moore M, Shea P, Schreckhise R, Bukowski TR, Presnell S, Guerra-Lewis P, Parrish-Novak J, Ellsworth JL, Jaspers S, Lewis KE, Appleby M, Kolls JK, Rixon M, West JW, Gao Z, Levin SD. J. Immunol. 179 5462-5473 (2007)
  12. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Ramirez-Carrozzi V, Sambandam A, Luis E, Lin Z, Jeet S, Lesch J, Hackney J, Kim J, Zhou M, Lai J, Modrusan Z, Sai T, Lee W, Xu M, Caplazi P, Diehl L, de Voss J, Balazs M, Gonzalez L, Singh H, Ouyang W, Pappu R. Nat. Immunol. 12 1159-1166 (2011)
  13. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Prabhala RH, Pelluru D, Fulciniti M, Prabhala HK, Nanjappa P, Song W, Pai C, Amin S, Tai YT, Richardson PG, Ghobrial IM, Treon SP, Daley JF, Anderson KC, Kutok JL, Munshi NC. Blood 115 5385-5392 (2010)
  14. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim SV, Hoeffer CA, Littman DR, Huh JR. Science 351 933-939 (2016)
  15. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Chang SH, Dong C. Cell Res. 17 435-440 (2007)
  16. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ, Tomkinson KN, Fitz LJ, Wolfman NM, Collins M, Dunussi-Joannopoulos K, Chatterjee-Kishore M, Carreno BM. J Immunol 181 2799-2805 (2008)
  17. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K. Br. J. Dermatol. 160 319-324 (2009)
  18. γδ T cells protect against lung fibrosis via IL-22. Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP. J. Exp. Med. 207 2239-2253 (2010)
  19. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K, Yamamoto K. J Immunol 179 7128-7136 (2007)
  20. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. Cheung PF, Wong CK, Lam CW. J Immunol 180 5625-5635 (2008)
  21. Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation. Veverka V, Henry AJ, Slocombe PM, Ventom A, Mulloy B, Muskett FW, Muzylak M, Greenslade K, Moore A, Zhang L, Gong J, Qian X, Paszty C, Taylor RJ, Robinson MK, Carr MD. J. Biol. Chem. 284 10890-10900 (2009)
  22. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW. Am. J. Pathol. 179 248-258 (2011)
  23. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H. J Immunol 188 3573-3583 (2012)
  24. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P. J Immunol 182 3112-3120 (2009)
  25. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Am. J. Respir. Crit. Care Med. 171 12-18 (2005)
  26. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. Zrioual S, Toh ML, Tournadre A, Zhou Y, Cazalis MA, Pachot A, Miossec V, Miossec P. J Immunol 180 655-663 (2008)
  27. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. Hu Y, Ota N, Peng I, Refino CJ, Danilenko DM, Caplazi P, Ouyang W. J Immunol 184 4307-4316 (2010)
  28. Evolutionary divergence and functions of the human interleukin (IL) gene family. Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V. Hum. Genomics 5 30-55 (2010)
  29. A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling. Yang RB, Ng CK, Wasserman SM, Kömüves LG, Gerritsen ME, Topper JN. J. Biol. Chem. 278 33232-33238 (2003)
  30. A protective role by interleukin-17F in colon tumorigenesis. Tong Z, Yang XO, Yan H, Liu W, Niu X, Shi Y, Fang W, Xiong B, Wan Y, Dong C. PLoS ONE 7 e34959 (2012)
  31. Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. Nagata T, McKinley L, Peschon JJ, Alcorn JF, Aujla SJ, Kolls JK. J Immunol 181 7473-7479 (2008)
  32. Evidence for ligand-independent multimerization of the IL-17 receptor. Kramer JM, Yi L, Shen F, Maitra A, Jiao X, Jin T, Gaffen SL. J. Immunol. 176 711-715 (2006)
  33. The enhancement of histone H4 and H2A serine 1 phosphorylation during mitosis and S-phase is evolutionarily conserved. Barber CM, Turner FB, Wang Y, Hagstrom K, Taverna SD, Mollah S, Ueberheide B, Meyer BJ, Hunt DF, Cheung P, Allis CD. Chromosoma 112 360-371 (2004)
  34. IL-17A controls IL-17F production and maintains blood neutrophil counts in mice. von Vietinghoff S, Ley K. J. Immunol. 183 865-873 (2009)
  35. Identification, cloning and characterization of interleukin-17 and its family from zebrafish. Gunimaladevi I, Savan R, Sakai M. Fish Shellfish Immunol. 21 393-403 (2006)
  36. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Debrue M, Hamilton E, Joubert P, Lajoie-Kadoch S, Lavoie JP. Vet. Immunol. Immunopathol. 105 25-31 (2005)
  37. REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. Yehuda S, Sredni B, Carasso RL, Kenigsbuch-Sredni D. J. Interferon Cytokine Res. 29 393-398 (2009)
  38. Role of IL-23 and Th17 Cells in Airway Inflammation in Asthma. Nakajima H, Hirose K. Immune Netw 10 1-4 (2010)
  39. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Paradowska-Gorycka A, Wojtecka-Lukasik E, Trefler J, Wojciechowska B, Lacki JK, Maslinski S. Scand. J. Immunol. 72 134-141 (2010)
  40. Rapid accumulation of an interleukin 17 homolog transcript in Crassostrea gigas hemocytes following bacterial exposure. Roberts S, Gueguen Y, de Lorgeril J, Goetz F. Dev. Comp. Immunol. 32 1099-1104 (2008)
  41. Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. Watanabe H, Kawaguchi M, Fujishima S, Ogura M, Matsukura S, Takeuchi H, Ohba M, Sueki H, Kokubu F, Hizawa N, Adachi M, Huang SK, Iijima M. J. Invest. Dermatol. 129 650-656 (2009)
  42. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. Iyoda M, Shibata T, Kawaguchi M, Hizawa N, Yamaoka T, Kokubu F, Akizawa T. Am. J. Physiol. Renal Physiol. 298 F779-87 (2010)
  43. IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. Inoue D, Numasaki M, Watanabe M, Kubo H, Sasaki T, Yasuda H, Yamaya M, Sasaki H. Biochem. Biophys. Res. Commun. 347 852-858 (2006)
  44. Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway. Kawaguchi M, Kokubu F, Odaka M, Watanabe S, Suzuki S, Ieki K, Matsukura S, Kurokawa M, Adachi M, Huang SK. J. Allergy Clin. Immunol. 114 444-450 (2004)
  45. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. Brucklacher-Waldert V, Steinbach K, Lioznov M, Kolster M, Hölscher C, Tolosa E. J Immunol 183 5494-5501 (2009)
  46. Structure of IL-17A in complex with a potent, fully human neutralizing antibody. Gerhardt S, Abbott WM, Hargreaves D, Pauptit RA, Davies RA, Needham MR, Langham C, Barker W, Aziz A, Snow MJ, Dawson S, Welsh F, Wilkinson T, Vaugan T, Beste G, Bishop S, Popovic B, Rees G, Sleeman M, Tuske SJ, Coales SJ, Hamuro Y, Russell C. J. Mol. Biol. 394 905-921 (2009)
  47. Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. Toh ML, Gonzales G, Koenders MI, Tournadre A, Boyle D, Lubberts E, Zhou Y, Firestein GS, van den Berg WB, Miossec P. PLoS ONE 5 e13416 (2010)
  48. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Shen N, Wang J, Zhao M, Pei F, He B. Inhal Toxicol 23 212-218 (2011)
  49. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. Rong Z, Wang A, Li Z, Ren Y, Cheng L, Li Y, Wang Y, Ren F, Zhang X, Hu J, Chang Z. Cell Res. 19 208-215 (2009)
  50. Polymorphisms in the interleukin 17F gene (IL17F) and asthma. Ramsey CD, Lazarus R, Camargo CA, Weiss ST, Celedón JC. Genes Immun. 6 236-241 (2005)
  51. Lamprey (Lethenteron japonicum) IL-17 upregulated by LPS-stimulation in the skin cells. Tsutsui S, Nakamura O, Watanabe T. Immunogenetics 59 873-882 (2007)
  52. The IL-17F signaling pathway is involved in the induction of IFN-gamma-inducible protein 10 in bronchial epithelial cells. Kawaguchi M, Kokubu F, Huang SK, Homma T, Odaka M, Watanabe S, Suzuki S, Ieki K, Matsukura S, Kurokawa M, Adachi M. J. Allergy Clin. Immunol. 119 1408-1414 (2007)
  53. Activation of extracellular signal-regulated kinase (ERK)1/2, but not p38 and c-Jun N-terminal kinase, is involved in signaling of a novel cytokine, ML-1. Kawaguchi M, Onuchic LF, Huang SK. J. Biol. Chem. 277 15229-15232 (2002)
  54. Expression of interleukin-17F in a mouse model of allergic asthma. Suzuki S, Kokubu F, Kawaguchi M, Homma T, Odaka M, Watanabe S, Ieki K, Matsukura S, Kurokawa M, Takeuchi H, Sasaki Y, Huang SK, Adachi M, Ota H. Int. Arch. Allergy Immunol. 143 Suppl 1 89-94 (2007)
  55. Prevalence and clinical relevance of Th17 cells in patients with gastric cancer. Yamada Y, Saito H, Ikeguchi M. J. Surg. Res. 178 685-691 (2012)
  56. Cloning and characterization of rainbow trout interleukin-17A/F2 (IL-17A/F2) and IL-17 receptor A: expression during infection and bioactivity of recombinant IL-17A/F2. Monte MM, Wang T, Holland JW, Zou J, Secombes CJ. Infect. Immun. 81 340-353 (2013)
  57. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. Chen Y, Yang P, Li F, Kijlstra A. PLoS ONE 6 e18139 (2011)
  58. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression. Kumar P, Natarajan K, Shanmugam N. Cell. Signal. 26 528-539 (2014)
  59. Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Jang WC, Nam YH, Ahn YC, Lee SH, Park SH, Choe JY, Lee SS, Kim SK. Rheumatol. Int. 29 173-178 (2008)
  60. IL-17 reduces TNF-induced Rantes and VCAM-1 expression. Schnyder B, Schnyder-Candrian S, Pansky A, Schmitz ML, Heim M, Ryffel B, Moser R. Cytokine 31 191-202 (2005)
  61. IL-17 is a neuromodulator of Caenorhabditis elegans sensory responses. Chen C, Itakura E, Nelson GM, Sheng M, Laurent P, Fenk LA, Butcher RA, Hegde RS, de Bono M. Nature 542 43-48 (2017)
  62. Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing. Kokubu T, Haudenschild DR, Moseley TA, Rose L, Reddi AH. J. Histochem. Cytochem. 56 89-95 (2008)
  63. The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor. Muller YA, Heiring C, Misselwitz R, Welfle K, Welfle H. J. Biol. Chem. 277 43410-43416 (2002)
  64. Interleukin-33 induces interleukin-17F in bronchial epithelial cells. Fujita J, Kawaguchi M, Kokubu F, Ohara G, Ota K, Huang SK, Morishima Y, Ishii Y, Satoh H, Sakamoto T, Hizawa N. Allergy 67 744-750 (2012)
  65. Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Liu S, Song X, Chrunyk BA, Shanker S, Hoth LR, Marr ES, Griffor MC. Nat Commun 4 1888 (2013)
  66. Genomics of fish cytokines. Savan R, Sakai M. Comp. Biochem. Physiol. Part D Genomics Proteomics 1 89-101 (2006)
  67. Interleukin-17D in Atlantic salmon (Salmo salar): molecular characterization, 3D modelling and promoter analysis. Kumari J, Larsen AN, Bogwald J, Dalmo RA. Fish Shellfish Immunol. 27 647-659 (2009)
  68. N-linked oligosaccharides play a role in disulphide-dependent dimerization of intestinal mucin Muc2. Bell SL, Xu G, Khatri IA, Wang R, Rahman S, Forstner JF. Biochem. J. 373 893-900 (2003)
  69. Two interleukin-17C-like genes exist in rainbow trout Oncorhynchus mykiss that are differentially expressed and modulated. Wang T, Martin SA, Secombes CJ. Dev. Comp. Immunol. 34 491-500 (2010)
  70. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis. Corneth OB, Mus AM, Asmawidjaja PS, Klein Wolterink RG, van Nimwegen M, Brem MD, Hofman Y, Hendriks RW, Lubberts E. 66 340-349 (2014)
  71. Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis. Xie Y, Sheng W, Xiang J, Ye Z, Yang J. Cancer Invest. 28 598-607 (2010)
  72. A distinct regulatory role of Th17 cytokines IL-17A and IL-17F in chemokine secretion from lung microvascular endothelial cells. Fujie H, Niu K, Ohba M, Tomioka Y, Kitazawa H, Nagashima K, Ohrui T, Numasaki M. Inflammation 35 1119-1131 (2012)
  73. IL-17A and IL-17F expression in B lymphocytes. Vazquez-Tello A, Halwani R, Li R, Nadigel J, Bar-Or A, Mazer BD, Eidelman DH, Al-Muhsen S, Hamid Q. Int. Arch. Allergy Immunol. 157 406-416 (2012)
  74. Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function. Andersson CK, Adams A, Nagakumar P, Bossley C, Gupta A, De Vries D, Adnan A, Bush A, Saglani S, Lloyd CM. J. Allergy Clin. Immunol. 139 1819-1829.e11 (2017)
  75. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. Bosmann M, Patel VR, Russkamp NF, Pache F, Zetoune FS, Sarma JV, Ward PA. FASEB J. 25 4222-4232 (2011)
  76. Blockade of Interplay between IL-17A and Endoplasmic Reticulum Stress Attenuates LPS-Induced Lung Injury. Kim SR, Kim HJ, Kim DI, Lee KB, Park HJ, Jeong JS, Cho SH, Lee YC. Theranostics 5 1343-1362 (2015)
  77. Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. DeForge LE, Loyet KM, Delarosa D, Chinn J, Zamanian F, Chuntharapai A, Lee J, Hass P, Wei N, Townsend MJ, Wang J, Wong WL. J. Immunol. Methods 362 70-81 (2010)
  78. IL-17 and IL-17F modulate GM-CSF production by lung microvascular endothelial cells stimulated with IL-1beta and/or TNF-alpha. Numasaki M, Tomioka Y, Takahashi H, Sasaki H. Immunol. Lett. 95 175-184 (2004)
  79. IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway. Kawaguchi M, Fujita J, Kokubu F, Huang SK, Homma T, Matsukura S, Adachi M, Hizawa N. Am. J. Physiol. Lung Cell Mol. Physiol. 296 L804-10 (2009)
  80. The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migration. Mayasundari A, Whittemore NA, Serpersu EH, Peterson CB. J. Biol. Chem. 279 29359-29366 (2004)
  81. Identification of the salmonid IL-17A/F1a/b, IL-17A/F2b, IL-17A/F3 and IL-17N genes and analysis of their expression following in vitro stimulation and infection. Wang T, Jiang Y, Wang A, Husain M, Xu Q, Secombes CJ. Immunogenetics 67 395-412 (2015)
  82. Interleukin-17A increases neurite outgrowth from adult postganglionic sympathetic neurons. Chisholm SP, Cervi AL, Nagpal S, Lomax AE. J. Neurosci. 32 1146-1155 (2012)
  83. Regulatory roles of IL-17 and IL-17F in G-CSF production by lung microvascular endothelial cells stimulated with IL-1beta and/or TNF-alpha. Numasaki M, Takahashi H, Tomioka Y, Sasaki H. Immunol. Lett. 95 97-104 (2004)
  84. Cloning and functional characterization of chicken interleukin-17D. Hong YH, Lillehoj HS, Park DW, Lee SH, Han JY, Shin JH, Park MS, Kim JK. Vet. Immunol. Immunopathol. 126 1-8 (2008)
  85. Cloning and characterization of Swine interleukin-17, preferentially expressed in the intestines. Katoh S, Kitazawa H, Shimosato T, Tohno M, Kawai Y, Saito T. J. Interferon Cytokine Res. 24 553-559 (2004)
  86. Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive esophagitis. Zayachkivska O, Havryluk O, Hrycevych N, Bula N, Grushka O, Wallace JL. PLoS ONE 9 e110688 (2014)
  87. Interleukin-17F-induced pulmonary microvascular endothelial monolayer hyperpermeability via the protein kinase C pathway. You QH, Sun GY, Wang N, Shen JL, Wang Y. J. Surg. Res. 162 110-121 (2010)
  88. Novel therapeutic targets along the Th17 pathway. Ouyang W, Filvaroff E, Hu Y, Grogan J. Eur. J. Immunol. 39 670-675 (2009)
  89. Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16. Gras R, Almonacid L, Ortega P, Serramia MJ, Gomez R, de la Mata FJ, Lopez-Fernandez LA, Muñoz-Fernandez MA. Pharm. Res. 26 577-586 (2009)
  90. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Glatt S, Baeten D, Baker T, Griffiths M, Ionescu L, Lawson ADG, Maroof A, Oliver R, Popa S, Strimenopoulou F, Vajjah P, Watling MIL, Yeremenko N, Miossec P, Shaw S. Ann. Rheum. Dis. 77 523-532 (2018)
  91. Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL. Wu B, Jin M, Zhang Y, Wei T, Bai Z. Immunogenetics 63 835-845 (2011)
  92. Genomic characterization and expression analysis of five novel IL-17 genes in the Pacific oyster, Crassostrea gigas. Li J, Zhang Y, Zhang Y, Xiang Z, Tong Y, Qu F, Yu Z. Fish Shellfish Immunol. 40 455-465 (2014)
  93. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins. Oftedal BEV, Kämpe O, Meager A, Ahlgren KM, Lobell A, Husebye ES, Wolff ASB. Scand. J. Immunol. 74 327-333 (2011)
  94. Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation. Hu MH, Zheng QF, Jia XZ, Li Y, Dong YC, Wang CY, Lin QY, Zhang FY, Zhao RB, Xu HW, Zhou JH, Yuan HP, Zhang WH, Ren H. Clin. Exp. Immunol. 175 268-284 (2014)
  95. The kinase PKCα selectively upregulates interleukin-17A during Th17 cell immune responses. Meisel M, Hermann-Kleiter N, Hinterleitner R, Gruber T, Wachowicz K, Pfeifhofer-Obermair C, Fresser F, Leitges M, Soldani C, Viola A, Kaminski S, Baier G. Immunity 38 41-52 (2013)
  96. Characterization and mucosal responses of interleukin 17 family ligand and receptor genes in channel catfish Ictalurus punctatus. Wang X, Li C, Thongda W, Luo Y, Beck B, Peatman E. Fish Shellfish Immunol. 38 47-55 (2014)
  97. Characterization of Lamprey IL-17 Family Members and Their Receptors. Han Q, Das S, Hirano M, Holland SJ, McCurley N, Guo P, Rosenberg CS, Boehm T, Cooper MD. J. Immunol. 195 5440-5451 (2015)
  98. The other T helper cells in asthma pathogenesis. Vock C, Hauber HP, Wegmann M. J Allergy (Cairo) 2010 519298 (2010)
  99. A knowledgebase resource for interleukin-17 family mediated signaling. Sharma J, Balakrishnan L, Datta KK, Sahasrabuddhe NA, Khan AA, Sahu A, Singhal A, Getnet D, Raju R, Chatterjee A, Gowda H, Keshava Prasad TS, Shankar S, Pandey A. J Cell Commun Signal 9 291-296 (2015)
  100. Common structural traits for cystine knot domain of the TGFβ superfamily of proteins and three-fingered ectodomain of their cellular receptors. Galat A. Cell. Mol. Life Sci. 68 3437-3451 (2011)
  101. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. Jia X, Hu M, Wang C, Wang C, Zhang F, Han Q, Zhao R, Huang Q, Xu H, Yuan H, Ren H. Mol. Vis. 17 1493-1507 (2011)
  102. IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases. Riedel JH, Paust HJ, Krohn S, Turner JE, Kluger MA, Steinmetz OM, Krebs CF, Stahl RA, Panzer U. J. Am. Soc. Nephrol. 27 3666-3677 (2016)
  103. Interleukin-17 potently increases non-small cell lung cancer growth. Wei L, Wang H, Yang F, Ding Q, Zhao J. Mol Med Rep 13 1673-1680 (2016)
  104. IL17 factors are early regulators in the gut epithelium during inflammatory response to Vibrio in the sea urchin larva. Buckley KM, Ho ECH, Hibino T, Schrankel CS, Schuh NW, Wang G, Rast JP. Elife 6 (2017)
  105. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes. Tanigawa S, Aida Y, Kawato T, Honda K, Nakayama G, Motohashi M, Suzuki N, Ochiai K, Matsumura H, Maeno M. Cytokine 56 376-386 (2011)
  106. Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris. Liu Y, Wu C, Wang J, Mo W, Yu M. Appl. Microbiol. Biotechnol. 97 10349-10358 (2013)
  107. Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling. Cole S, Murray J, Simpson C, Okoye R, Tyson K, Griffiths M, Baeten D, Shaw S, Maroof A. Front Immunol 11 585134 (2020)
  108. Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungs. Xu X, Shao B, Wang R, Zhou S, Tang Z, Lu W, Xiong S. Int J Clin Exp Med 7 809-816 (2014)
  109. Assignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasma. Horn NA, Hurst GB, Mayasundari A, Whittemore NA, Serpersu EH, Peterson CB. J. Biol. Chem. 279 35867-35878 (2004)
  110. Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Liu S, Dakin LA, Xing L, Withka JM, Sahasrabudhe PV, Li W, Banker ME, Balbo P, Shanker S, Chrunyk BA, Guo Z, Chen JM, Young JA, Bai G, Starr JT, Wright SW, Bussenius J, Tan S, Gopalsamy A, Lefker BA, Vincent F, Jones LH, Xu H, Hoth LR, Geoghegan KF, Qiu X, Bunnage ME, Thorarensen A. Sci Rep 6 30859 (2016)
  111. Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue: Ex vivo and in vitro studies. Montalbano AM, Riccobono L, Siena L, Chiappara G, Di Sano C, Anzalone G, Gagliardo R, Ricciardolo FLM, Sorbello V, Pipitone L, Vitulo P, Profita M. Cytokine 76 391-402 (2015)
  112. Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies. Basha HI, Ramachandran S, Tiriveedhi V, Takenaka M, Subramanian V, Nath DS, Benshoff N, Patterson GA, Mohanakumar T. Transplantation 95 293-300 (2013)
  113. Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels. Harris SJ, Ciuclan L, Finan PM, Wymann MP, Walker C, Westwick J, Ward SG, Thomas MJ. Eur. J. Immunol. 42 3394-3404 (2012)
  114. IL-17A stimulates granulocyte colony-stimulating factor production via ERK1/2 but not p38 or JNK in human renal proximal tubular epithelial cells. Hirai Y, Iyoda M, Shibata T, Kuno Y, Kawaguchi M, Hizawa N, Matsumoto K, Wada Y, Kokubu F, Akizawa T. Am. J. Physiol. Renal Physiol. 302 F244-50 (2012)
  115. Th-17 cells in the lungs? Ivanov S, Lindén A. Expert Rev Respir Med 1 279-293 (2007)
  116. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. Ho AW, Garg AV, Monin L, Simpson-Abelson MR, Kinner L, Gaffen SL. PLoS ONE 8 e70168 (2013)
  117. The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ. Arthritis 2011 810649 (2011)
  118. MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors. Mai J, Virtue A, Maley E, Tran T, Yin Y, Meng S, Pansuria M, Jiang X, Wang H, Yang XF. Front Biosci (Elite Ed) 4 1478-1495 (2012)
  119. Organizing structural principles of the IL-17 ligand-receptor axis. Wilson SC, Caveney NA, Yen M, Pollmann C, Xiang X, Jude KM, Hafer M, Tsutsumi N, Piehler J, Garcia KC. Nature 609 622-629 (2022)
  120. A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It. Tamassia N, Arruda-Silva F, Calzetti F, Lonardi S, Gasperini S, Gardiman E, Bianchetto-Aguilera F, Gatta LB, Girolomoni G, Mantovani A, Vermi W, Cassatella MA. Front Immunol 9 795 (2018)
  121. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment. Marwa OS, Kalthoum T, Wajih K, Kamel H. Immunol. Lett. 183 24-36 (2017)
  122. Comparative and Evolutionary Analysis of the Interleukin 17 Gene Family in Invertebrates. Huang XD, Zhang H, He MX. PLoS ONE 10 e0132802 (2015)
  123. Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial. Glatt S, Jemec GBE, Forman S, Sayed C, Schmieder G, Weisman J, Rolleri R, Seegobin S, Baeten D, Ionescu L, Zouboulis CC, Shaw S. JAMA Dermatol 157 1279-1288 (2021)
  124. Expression, refolding and purification of a human interleukin-17A variant. Wu B, Nemeth JF, Janecki DJ, Jones B, Obmolova G, Malia TJ, Baker A, Bethea D, Elloso MM, Naso M, Taudte S. Cytokine 53 107-114 (2011)
  125. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome. Gan Y, Zhao X, He J, Liu X, Li Y, Sun X, Li Z. J Immunol Res 2017 4768408 (2017)
  126. Interleukin-17A Causes Osteoarthritis-Like Transcriptional Changes in Human Osteoarthritis-Derived Chondrocytes and Synovial Fibroblasts In Vitro. Mimpen JY, Baldwin MJ, Cribbs AP, Philpott M, Carr AJ, Dakin SG, Snelling SJB. Front Immunol 12 676173 (2021)
  127. Application of MALDI TOF/TOF mass spectrometry and collision-induced dissociation for the identification of disulfide-bonded peptides. Janecki DJ, Nemeth JF. J Mass Spectrom 46 677-688 (2011)
  128. Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes. Ramirez-Carrozzi V, Ota N, Sambandam A, Wong K, Hackney J, Martinez-Martin N, Ouyang W, Pappu R. J Immunol 202 1935-1941 (2019)
  129. Effects of recombinant IL-17F intranasal inoculation against Streptococcus pneumoniae infection in a murine model. Chen L, Guo S, Wu L, Hao C, Xu W, Zhang J. Biotechnol. Appl. Biochem. 62 393-400 (2015)
  130. IL-17F Induces CCL20 in Bronchial Epithelial Cells. Nozato K, Fujita J, Kawaguchi M, Ohara G, Morishima Y, Ishii Y, Huang SK, Kokubu F, Satoh H, Hizawa N. J Allergy (Cairo) 2011 587204 (2011)
  131. IL-17F regulates psoriasis-associated genes through IκBζ. Bertelsen T, Ljungberg C, Boye Kjellerup R, Iversen L, Johansen C. Exp. Dermatol. 26 234-241 (2017)
  132. Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis. Vrgoc G, Vrbanec J, Eftedal RK, Dembic PL, Balen S, Dembic Z, Jotanovic Z. J. Orthop. Res. 36 1684-1693 (2018)
  133. Fatty acids rehabilitated long-term neurodegenerative: like symptoms in olfactory bulbectomized rats. Yehuda S, Rabinovitz S. J Neural Transm (Vienna) 122 629-641 (2015)
  134. Genetic Analysis of IL-17 Gene Polymorphisms in Gout in a Male Chinese Han Population. Zhou Z, Li X, Li H, Guo M, Liu S, Li C. PLoS ONE 11 e0148082 (2016)
  135. IL-17F induces IL-6 via TAK1-NFκB pathway in airway smooth muscle cells. Nakajima M, Kawaguchi M, Ota K, Fujita J, Matsukura S, Huang SK, Morishima Y, Ishii Y, Satoh H, Sakamoto T, Hizawa N. Immun Inflamm Dis 5 124-131 (2017)
  136. Immune responses to self-antigens (autoimmunity) in allograft rejection. Ramachandran S, Subramanian V, Mohanakumar T. Clin Transpl 261-272 (2012)
  137. Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway. Yang J, Kou J, Lim JE, Lalonde R, Fukuchi KI. Brain Behav. Immun. 53 84-95 (2016)
  138. Life before seventeen: cloning of the IL-17 receptor. Gaffen SL. J. Immunol. 187 4389-4391 (2011)
  139. Molecular cloning of chicken interleukin-17B, which induces proinflammatory cytokines through activation of the NF-κB signaling pathway. Hoang CT, Hong Y, Truong AD, Lee J, Lee K, Hong YH. Dev. Comp. Immunol. 74 40-48 (2017)
  140. Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells. Nakajima M, Kawaguchi M, Matsuyama M, Ota K, Fujita J, Matsukura S, Huang SK, Morishima Y, Ishii Y, Satoh H, Sakamoto T, Hizawa N. Int. Arch. Allergy Immunol. 176 83-90 (2018)
  141. Association of single nucleotide polymorphisms of IL23R and IL17 with necrotizing enterocolitis in premature infants. Tian J, Liu Y, Jiang Y, Zhou H, Zhu T, Zhao X, Peng L, Yan C. Mol. Cell. Biochem. 430 201-209 (2017)
  142. Autoimmunity to neuroretina in the concurrent absence of IFN-γ and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation. Bing SJ, Silver PB, Jittayasothorn Y, Mattapallil MJ, Chan CC, Horai R, Caspi RR. J Autoimmun 114 102507 (2020)
  143. Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F. Adams R, Maroof A, Baker T, Lawson ADG, Oliver R, Paveley R, Rapecki S, Shaw S, Vajjah P, West S, Griffiths M. Front Immunol 11 1894 (2020)
  144. Cross-sectional and longitudinal associations between serum inflammatory cytokines and knee bone marrow lesions in patients with knee osteoarthritis. Zhu Z, Otahal P, Wang B, Jin X, Laslett LL, Wluka AE, Antony B, Han W, Wang X, Winzenberg T, Cicuttini F, Jones G, Ding C. Osteoarthr. Cartil. 25 499-505 (2017)
  145. Elevated autoantibodies against interleukin-17F correlate with disease activity in patients with early rheumatoid arthritis. Yang L, Bai L, Wei F, Liu Y, Sun L, Wang W, Liu X, Wang Y. Int J Rheum Dis 19 644-650 (2016)
  146. Expression and Function Analysis of Interleukin-17A/F1, 2, and 3 Genes in Yellow Catfish (Pelteobagrus fulvidraco): Distinct Bioactivity of Recombinant IL-17A/F1, 2, and 3. Zhou X, Zhang GR, Ji W, Shi ZC, Ma XF, Luo ZL, Wei KJ. Front Immunol 12 626895 (2021)
  147. Generation of glycosylphosphatidylinositol linked chicken IL-17 to generate specific monoclonal antibodies applicable for intracellular cytokine staining. Walliser I, Göbel TW. Dev. Comp. Immunol. 73 27-35 (2017)
  148. Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum. Navrazhina K, Frew JW, Grand D, Williams SC, Hur H, Gonzalez J, Garcet S, Krueger JG. Br J Dermatol 187 223-233 (2022)
  149. Optimal Biologic Drugs for the Treatment of Ankylosing Spondylitis: Results from a Network Meta-Analysis and Network Metaregression. Cao Z, Guo J, Li Q, Li Y, Wu J. Biomed Res Int 2022 8316106 (2022)
  150. Protective Role of IL7A-197 A/G Heterozygosity in the Development and Severity of Colorectal Cancer in the Bulgarian Population. Aleksandrova E, Vlaykova T, Ananiev J, Gulubova M. Medicina (Kaunas) 58 1632 (2022)
  151. Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma. Evasovic JM, Singer CA. Am J Physiol Lung Cell Mol Physiol 316 L843-L868 (2019)
  152. Relationship Between Serum Interleukin-17F Level and Severity of Atopic Dermatitis in Children. Park YA, Kim YH, Sol IS, Yoon SH, Hong JY, Kim MN, Lee KE, Kim KW, Kim KE, Sohn MH. Pediatr Allergy Immunol Pulmonol 28 112-116 (2015)
  153. The role of interchain disulfide bond in a recombinant human interleukin-17A variant. Wu B, Muzammil S, Jones B, Nemeth JF, Janecki DJ, Baker A, Merle Elloso M, Naso M, Carton J, Taudte S. Cytokine 65 167-174 (2014)
  154. A new method for the treatment of myocardial ischemia-reperfusion injury based on γδT cell-mediated immune response. Luo W, Bian X, Liu X, Zhang W, Xie Q, Feng L. Front Cardiovasc Med 10 1219316 (2023)
  155. Analytical Computation of Interleukin17A Activity in Breast Cancer Patients Using Bioinformatics Methods. Mohammed AS, Al-Janabi AA. Arch Razi Inst 76 895-901 (2021)
  156. Association of Interleukin-17F 7488A/G and 7383A/G Polymorphisms With Rheumatoid Arthritis: A Meta-Analysis. Chen P, He G, Yang Y, Yang Y, Li L. Arch Rheumatol 34 148-156 (2019)
  157. Challenge of Bovine Foot Skin Fibroblasts With Digital Dermatitis Treponemes Identifies Distinct Pathogenic Mechanisms. Newbrook K, Carter SD, Crosby-Durrani H, Evans NJ. Front Cell Infect Microbiol 10 538591 (2020)
  158. Characterization of the interleukin-17 effect on articular cartilage in a translational model: an explorative study. Sinkeviciute D, Aspberg A, He Y, Bay-Jensen AC, Önnerfjord P. BMC Rheumatol 4 30 (2020)
  159. Cloning and characterization of two duplicated interleukin-17A/F2 genes in common carp (Cyprinus carpio L.): Transcripts expression and bioactivity of recombinant IL-17A/F2. Li H, Yu J, Li J, Tang Y, Yu F, Zhou J, Yu W. Fish Shellfish Immunol. 51 303-312 (2016)
  160. Combination of IL-17A/F and TNF-α uniquely alters the bronchial epithelial cell proteome to enhance proteins that augment neutrophil migration. Altieri A, Piyadasa H, Hemshekhar M, Osawa N, Recksiedler B, Spicer V, Hiemstra PS, Halayko AJ, Mookherjee N. J Inflamm (Lond) 19 26 (2022)
  161. Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis. Gao W, Yu B, Yan Y, Zhao L, Zhao R. Front Immunol 14 1151977 (2023)
  162. Differential Spleen miRNA Expression Profile of Beagle Dogs Infected with Toxocara canis. Xu Y, Li HY, Cai L, Xie SC, Zou Y, Zhu XQ, Zheng WB. Animals (Basel) 12 2638 (2022)
  163. Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. van der Heijde D, Gensler LS, Deodhar A, Baraliakos X, Poddubnyy D, Kivitz A, Farmer MK, Baeten D, Goldammer N, Coarse J, Oortgiesen M, Dougados M. Ann. Rheum. Dis. 79 595-604 (2020)
  164. Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study. Glatt S, Taylor PC, McInnes IB, Schett G, Landewé R, Baeten D, Ionescu L, Strimenopoulou F, Watling MIL, Shaw S. Ann. Rheum. Dis. 78 1033-1040 (2019)
  165. Epitope-Targeted Macrocyclic Peptide Ligand with Picomolar Cooperative Binding to Interleukin-17F. Lai BT, Wilson JA, Malette Loredo J, Pitram SM, LaBerge NA, Heath JR, Agnew HD. Chemistry 24 3760-3767 (2018)
  166. Evolutionary Insights into IL17A in Lagomorphs. Neves F, Abrantes J, Almeida T, Costa PP, Esteves PJ. Mediators Inflamm. 2015 367670 (2015)
  167. Exploring the Role of a Novel Interleukin-17 Homolog from Invertebrate Marine Mussel Mytilus coruscus in Innate Immune Response: Is Negative Regulation by Mc-Novel_miR_145 the Key? Chen X, Qiu L, Si X, Zhang X, Guo B, Liao Z, Yan X, Qi P. Int J Mol Sci 24 5928 (2023)
  168. IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis. Kurte M, Luz-Crawford P, Vega-Letter AM, Contreras RA, Tejedor G, Elizondo-Vega R, Martinez-Viola L, Fernández-O'Ryan C, Figueroa FE, Jorgensen C, Djouad F, Carrión F. Front Immunol 9 802 (2018)
  169. Interleukine-17 Modulates Neurogenesis and Behavior Following Exposure to Trauma in Mice. Willinger Y, Turgeman G. Cells 11 343 (2022)
  170. Interplay between SMAD2 and STAT5A is a critical determinant of IL-17A/IL-17F differential expression. Corral-Jara KF, Chauvin C, Abou-Jaoudé W, Grandclaudon M, Naldi A, Soumelis V, Thieffry D. Mol Biomed 2 9 (2021)
  171. Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides. Dong Z, Zhu X, Li Y, Gan L, Chen H, Zhang W, Sun J. Medicine (Baltimore) 97 e10871 (2018)
  172. Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine. Zhang Z, Jiang Z, Deng T, Zhang J, Liu B, Liu J, Qiu R, Zhang Q, Li X, Nian X, Hong Y, Li F, Peng F, Zhao W, Xia Z, Huang S, Liang S, Chen J, Li C, Yang X. Open Life Sci 17 1282-1295 (2022)
  173. Role of Th17-cell related cytokines in geriatric asthma. Quan-San Z, Xiaohong X, Ying L, Zhaojia S. J. Int. Med. Res. 47 580-590 (2019)
  174. T cell transgressions: Tales of T cell form and function in diverse disease states. Harris KM, Clements MA, Kwilasz AJ, Watkins LR. Int Rev Immunol 1-42 (2021)
  175. The Evolution and Diversity of Interleukin-17 Highlight an Expansion in Marine Invertebrates and Its Conserved Role in Mucosal Immunity. Saco A, Rey-Campos M, Rosani U, Novoa B, Figueras A. Front Immunol 12 692997 (2021)
  176. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. Wu X, Xia T, Shin WJ, Yu KM, Jung W, Herrmann A, Foo SS, Chen W, Zhang P, Lee JS, Poo H, Comhair SAA, Jehi L, Choi YK, Ensser A, Jung JU. mBio 13 e0040222 (2022)
  177. lncRNA IL-17RA-1 Attenuates LPS-Induced Sepsis via miR-7847-3p/PRKCG-Mediated MAPK Signaling Pathway. Gan Y, Long J, Zeng Y, Zhang Y, Tao Y. Mediators Inflamm 2022 9923204 (2022)


Quick links